Neurological assessments

BEHAVIORAL6 trials

Sponsors

University Hospital, Bordeaux, Institut National de la Santé Et de la Recherche Médicale, France, Centre Hospitalier Universitaire de Nice, University of Pennsylvania

Conditions

ALSAmyotrophic Lateral SclerosisHealthy SubjectsHuntington DiseaseTauopathiesWhite Matter Alterations

Early Phase 1

Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-HY-2-15

RecruitingNCT06032026

University of PennsylvaniaTauopathies

Start: 2023-07-20End: 2028-07-31Target: 70Updated: 2025-11-19

Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503

RecruitingNCT06303921

University of PennsylvaniaTauopathies

Start: 2024-02-16End: 2029-02-28Target: 70Updated: 2025-04-22

Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A

RecruitingNCT06932809

University of PennsylvaniaTauopathies

Start: 2025-05-09End: 2030-04-30Target: 90Updated: 2025-12-23

Unknown Phase

Study of miRNA Expression Pattern as Diagnostic and Prognostic Biomarker in Amyotrophic Lateral Sclerosis

TerminatedNCT01992029

University Hospital, BordeauxALS, Amyotrophic Lateral Sclerosis

Start: 2014-06-17End: 2015-10-22Updated: 2018-11-05

Decoding Presymptomatic White Matter Changes in Huntington Disease

CompletedNCT03193099

Institut National de la Santé Et de la Recherche Médicale, FranceHuntington Disease, White Matter Alterations

Start: 2017-07-11End: 2019-12-30Updated: 2020-02-18

Cohort of Healthy People in Brain MRI, Together With a Language and Cognitive Assessment at the University Hospital of Nice

CompletedNCT04934033

Centre Hospitalier Universitaire de NiceHealthy Subjects

Start: 2021-08-23End: 2022-06-20Updated: 2022-07-05

Related Papers

Mechanism and Therapeutic Prospect of miRNAs in Neurodegenerative Diseases.

2023-11-2312 citations